Literature DB >> 2107969

Cloning of the genes for T84.66, an antibody that has a high specificity and affinity for carcinoembryonic antigen, and expression of chimeric human/mouse T84.66 genes in myeloma and Chinese hamster ovary cells.

M Neumaier1, L Shively, F S Chen, F J Gaida, C Ilgen, R J Paxton, J E Shively, A D Riggs.   

Abstract

Carcinoembryonic antigen (CEA) is one of the best characterized tumor-associated antigens and is extensively used in the in vitro immunodiagnosis of human colon adenocarcinomas. Among a number of anti-CEA monoclonal antibodies, the murine monoclonal antibody T84.66 shows the highest specificity and affinity for CEA and has been used successfully for in vivo tumor imaging in mice and humans. We report here the cloning and sequencing of the genes coding for monoclonal antibody T84.66 and the amino acid sequence of the variable regions for the heavy and light chains. We also report the construction of mouse/human chimeric IgG1 antibody genes using T84.66 variable region genes and human constant region genes. The resulting chimeric gene constructs were transfected into murine myeloma cells (Sp2/0) by electroporation and into Chinese hamster ovary cells by lipofection. The chimeric antibodies obtained exhibited the same specificity and affinity for CEA as that of the T84.66 immunoglobulin produced by the murine hybridoma cell line. Antibody concentrations in culture medium supernatants were clonally variable but similar (15-480 ng/ml) for both Sp2/0 and Chinese hamster ovary transfectants; the average production by Chinese hamster ovary transfectants was only 3-5-fold less than Sp2/0 transfectants. Ascites production of Sp2/0 transfectants is sufficiently high (900 micrograms/ml) for initial in vivo studies with humanized T84.66.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107969

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies.

Authors:  E Stöger; C Vaquero; E Torres; M Sack; L Nicholson; J Drossard; S Williams; D Keen; Y Perrin; P Christou; R Fischer
Journal:  Plant Mol Biol       Date:  2000-03       Impact factor: 4.076

2.  Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.

Authors:  Vania Kenanova; Tove Olafsen; Desiree M Crow; Gobalakrishnan Sundaresan; Murugesan Subbarayan; Nora H Carter; David N Ikle; Paul J Yazaki; Arion F Chatziioannou; Sanjiv S Gambhir; Lawrence E Williams; John E Shively; David Colcher; Andrew A Raubitschek; Anna M Wu
Journal:  Cancer Res       Date:  2005-01-15       Impact factor: 12.701

3.  Metabolic biotinylation of recombinant antibody by biotin ligase retained in the endoplasmic reticulum.

Authors:  Bhaswati Barat; Anna M Wu
Journal:  Biomol Eng       Date:  2007-02-15

4.  Measurement of mass transport and reaction parameters in bulk solution using photobleaching. Reaction limited binding regime.

Authors:  E N Kaufman; R K Jain
Journal:  Biophys J       Date:  1991-09       Impact factor: 4.033

5.  Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves.

Authors:  C Vaquero; M Sack; J Chandler; J Drossard; F Schuster; M Monecke; S Schillberg; R Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

6.  Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies.

Authors:  David Akhavan; Paul Yazaki; Dave Yamauchi; Jennifer Simpson; Paul H Frankel; James Bading; David Colcher; Kofi Poku; Yi-Jen Chen; Dean Lim; Mihaela Cristea; Anna Wu; John Shively; Jeffrey Y C Wong
Journal:  Cancer Biother Radiopharm       Date:  2020-01-07       Impact factor: 3.099

7.  PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study.

Authors:  Meong Cheol Shin; Jian Zhang; Kyoung Ah Min; Huining He; Allan E David; Yongzhuo Huang; Victor C Yang
Journal:  Pharm Res       Date:  2015-02-21       Impact factor: 4.200

8.  High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment.

Authors:  A M Wu; P J Yazaki; S w Tsai; K Nguyen; A L Anderson; D W McCarthy; M J Welch; J E Shively; L E Williams; A A Raubitschek; J Y Wong; T Toyokuni; M E Phelps; S S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

9.  Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy.

Authors:  Jeffrey N Bryan; Fang Jia; Huma Mohsin; Geethapriya Sivaguru; Carolyn J Anderson; William H Miller; Carolyn J Henry; Michael R Lewis
Journal:  Cancer Biol Ther       Date:  2011-06-15       Impact factor: 4.742

10.  124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.

Authors:  Gobalakrishnan Sundaresan; Paul J Yazaki; John E Shively; Ronald D Finn; Steven M Larson; Andrew A Raubitschek; Lawrence E Williams; Arion F Chatziioannou; Sanjiv S Gambhir; Anna M Wu
Journal:  J Nucl Med       Date:  2003-12       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.